BRAINSTORM CELL THERAPEUTICS INC. (BCLI) › Operating IncomeBRAINSTORM CELL THERAPEUTICS INC. (BCLI) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2010: $2.40M2011: -$3.91M2012: -$3.42M2013: -$4.90M2014: -$7.42M2015: -$8.54M2016: -$5.08M2017: -$5.00M2018: -$14.06M2019: -$23.00M2020: -$31.68M2021: -$24.54M2022: -$24.82M2023: -$21.44M2024: -$11.69M2025: -$9.95M-$9.95M2010Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$9.95M+14.9%2024-$11.69M+45.5%2023-$21.44M+13.6%2022-$24.82M-1.2%2021-$24.54M+22.6%2020-$31.68M-37.8%2019-$23.00M-63.6%2018-$14.06M-181.3%2017-$5.00M+1.7%2016-$5.08M+40.5%2015-$8.54M-15.0%2014-$7.42M-51.5%2013-$4.90M-43.0%2012-$3.42M+12.5%2011-$3.91M-263.0%2010$2.40M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share